(Q38482066)

3 September 2017

Reduction in long-term functional disability in rheumatoid arthritis from 1977 to 1998:a longitudinal study of 3035 patients (English)

1 reference

3 September 2017

0 references

0 references

Eswar Krishnan

1

1 reference

3 September 2017

James F. Fries

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14553872

20 March 2024

language of work or name

English

0 references

publication date

1 October 2003

1 reference

full work available at URL

3 September 2017

https://api.elsevier.com/content/article/PII:S0002934303003978?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0002-9343(03)00397-8

https://api.elsevier.com/content/article/PII:S0002934303003978?httpAccept=text/plain

20 March 2024

1 reference

https://api.crossref.org/works/10.1016/S0002-9343(03)00397-8

American Journal of Medicine

20 March 2024

published in

1 reference

3 September 2017

115

1 reference

3 September 2017

371-376

1 reference

3 September 2017

5

1 reference

A randomized trial of hydroxychloroquine in early rheumatoid arthritis: the HERA Study

3 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900397-8

Should disease-modifying agents be used in mild rheumatoid arthritis?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900397-8

Sulfasalazine in early rheumatoid arthritis. A 48-week double-blind, prospective, placebo-controlled study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900397-8

The effect of treatment on radiological progression in rheumatoid arthritis: a systematic review of randomized placebo-controlled trials.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900397-8

The comparative efficacy and toxicity of second-line drugs in rheumatoid arthritis results of two metaanalyses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900397-8

Improved functional outcome in patients with early rheumatoid arthritis treated with intramuscular gold: results of a five year prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900397-8

The effectiveness of early treatment with "second-line" antirheumatic drugs. A randomized, controlled trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900397-8

Early referral and outcome in rheumatoid arthritis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900397-8

The paradox of effective therapies but poor long-term outcomes in rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900397-8

Disease-modifying anti-rheumatic drug use according to the 'sawtooth' treatment strategy improves the functional outcome in rheumatoid arthritis: results of a long-term follow-up study with review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900397-8

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900397-8

Measurement of patient outcome in arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900397-8

Determining minimally important changes in generic and disease-specific health-related quality of life questionnaires in clinical trials of rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900397-8

Statistical methods for assessing agreement between two methods of clinical measurement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900397-8

Trends in incidence and mortality in rheumatoid arthritis in Rochester, Minnesota, over a forty-year period

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900397-8

Is rheumatoid arthritis becoming less severe?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900397-8

An epidemiologic study of trends in prevalence of rheumatoid factor seropositivity in Pima Indians: evidence of a decline due to both secular and birth-cohort influences

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900397-8

Changes in the prevalence of chronic disability in the United States black and nonblack population above age 65 from 1982 to 1999

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900397-8

Reducing disability in older age.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900397-8

Functional disability in rheumatoid arthritis patients compared with a community population in Finland

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900397-8

The mortality of rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900397-8

The impact of rheumatoid arthritis on employment status in the early years of disease: a UK community-based study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900397-8

Relationship of radiological change to clinical outcome in rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900397-8

Sensitivity to change of the health assessment questionnaire (HAQ) and other clinical and health status measures in rheumatoid arthritis: results of short-term clinical trials and observational studies versus long-term observational studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900397-8

inferred from DOI database lookup

7 January 2021

based on heuristic

Trends in the incidence and severity of rheumatoid arthritis

series ordinal

32

1 reference

https://api.crossref.org/works/10.1016/S0002-9343(03)00397-8

Moderate-term, low-dose corticosteroids for rheumatoid arthritis

20 March 2024

series ordinal

44

1 reference

https://api.crossref.org/works/10.1016/S0002-9343(03)00397-8

20 March 2024

Identifiers

1 reference

3 September 2017

1 reference